ArriVent BioPharma (AVBP) Q2 2024 Earnings

8MayConfirmed
Q2 2024
-1.08
-0.95
-0.83
-0.7

Details

Expected EPS
-1.077197
Actual EPS
-0.7
Surprise EPS
0.38
Surprise Percent
+35.02%

Description

ArriVent BioPharma (AVBP) has reported earnings of -0.7 per share for Q2 2024.

0 Comments

Share your thoughts